- KSC 2020 : 대한심장학회 제64차 추계학술대회
- 10.11 Thu. - 13 Sat. / Grand Walkerhill Seoul, Korea
Program at a Glance
- 현재 페이지 경로
> Program > Program at a Glance
Symposium
- Cardiometabolic Syndrome
- Update in SGLT2 Inhibitors from Cardiometabolic Perspective
- Oct. 16 (Fri.) 08:40-10:10, Channel 01
- Chairpersons: Sang-Hyun Kim, Seung Hwan Han
- Panel: Se Eun Park, Chan Joo Lee
-
08:40 - 09:00
-
HFpEF Malady, Model, Mechanism
[Speaker] Joseph A. Hill/UT Southwestern Medical Center,USA
-
09:00 - 09:20
-
SGLT2 Inhibitors Are Heart Failure Drug
[Speaker] Jin Joo Park/Seoul National Univ.,Korea
-
09:20 - 09:40
-
No, SGLT2 Inhibitors Are Antidiabetic Medication
[Speaker] Jun Hwa Hong/Eulji Univ.,Korea
-
09:40 - 10:00
-
Side Effect in SGLT2 Inhibitor
[Speaker] Sang Man Jin/Sungkyunkwan Univ.,Korea
-
10:00 - 10:10
-
Discussion
- The Korean Society of Cardiology
-
101-1704, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul, 04146, Republic of Korea
Copyright©2020 The Korean Society of Cardiology. All rights reserved.
